Castle Biosciences' Abstracts at Digestive Disease Week (DDW) Annual Meeting Selected as Posters of Distinction by the American Gastroenterological Association (AGA) Institute Council

New data demonstrate the risk-stratification performance and potential of the TissueCypher® Barrett’s Esophagus test to guide risk-aligned patient care decisions

... | May 26, 2023

Related Keywords

United States ,Amsterdam ,Noord Holland ,Netherlands ,American ,Jacques Bergman ,Robert Cook ,Castle Biosciences ,Michael Yodice ,Facebook ,American Gastroenterological Association ,American Society For Gastrointestinal Endoscopy ,Castle Biosciences Inc ,Nasdaq ,Geisinger Health ,Society For Surgery Of The Alimentary Tract ,Laboratory Developed Test ,Amsterdam University Medical Centers ,Instagram ,Centers For Medicare Medicaid Services ,Twitter ,Institute Council ,Linkedin ,Laboratory Test ,Study Author ,Risk Aligned Management ,Senior Author ,Tissue Systems Pathology Test ,Significant Clinical Utility ,Standardize Management Leading ,Improved Health Outcomes ,Esophagus Patients ,Low Grade Dysplasia ,Senior Author Jacques Bergman ,Digestive Disease Week ,Disease Week ,American Association ,Liver Diseases ,American Society ,Gastrointestinal Endoscopy ,Alimentary Tract ,Tissuecypher Barrett ,Esophagus Assay ,Advanced Diagnostic Laboratory Test ,Medicaid Services ,Practice Update ,Mypath Melanoma ,Nc Stock Exchange ,News ,Information ,Press Release ,Few ,Data ,Emonstrate ,The ,Performance ,End ,Potential ,F ,Esophagus ,Pest ,O ,Uide ,Patient ,Are Cstl Us14843c1053 ,